CoChat
Sign Up
Cited by 132

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy

Batzner, Angelika, Pfeiffer, Barbara, Neugebauer, Anna, Aicha, Diaa, Blank, Christoph, Seggewiss, Hubert·2018·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2018.09.064
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2018.09.064

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 27

  1. Semsarian, 2015, New perspectives on the prevalence of hypertrophic cardiomyopathy, J Am Coll Cardiol, 65, 1249, 10.1016/j.jacc.2015.01.019 · DOI
  2. Heric, 1995, Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results, J Thorac Cardiovasc Surg, 110, 195, 10.1016/S0022-5223(05)80026-1 · DOI
  3. Nishimura, 2017, Hypertrophic obstructive cardiomyopathy: surgical myectomy and septal ablation, Circ Res, 121, 771, 10.1161/CIRCRESAHA.116.309348 · DOI
  4. Sigwart, 1995, Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy, Lancet, 346, 211, 10.1016/S0140-6736(95)91267-3 · DOI
  5. Seggewiss, 1998, Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients, J Am Coll Cardiol, 31, 252, 10.1016/S0735-1097(97)00508-1 · DOI
  6. Gietzen, 1999, Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy, Eur Heart J, 20, 1342, 10.1053/euhj.1999.1520 · DOI
  7. Faber, 1998, Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography, Circulation, 98, 2415, 10.1161/01.CIR.98.22.2415 · DOI
  8. Seggewiss, 2007, Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy, Clin Res Cardiol, 96, 856, 10.1007/s00392-007-0579-8 · DOI
  9. Goodwin, 1995, Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy, Lancet, 346, 1624, 10.1016/S0140-6736(95)91954-6 · DOI
  10. Geske, 2014, Myectomy versus alcohol septal ablation: experience remains key, J Am Coll Cardiol Intv, 7, 1235, 10.1016/j.jcin.2014.05.022 · DOI
  11. Pfeiffer, 2012, [Myocardial contrast echocardiography guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy with a new echocardiographic contrast agent], Dtsch Med Wochenschr, 137, 2093
  12. Koljaja-Batzner, 2018, Septal collateralization to right coronary artery in alcohol septal ablation. solution to a dangerous pitfall, J Am Coll Cardiol Intv, 11, 2009, 10.1016/j.jcin.2018.05.034 · DOI
  13. Elliott, 2014, 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC), Eur Heart J, 35, 2733, 10.1093/eurheartj/ehu284 · DOI · Paper page
  14. Maron, 2003, Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy, N Engl J Med, 348, 295, 10.1056/NEJMoa021332 · DOI · Paper page
  15. Maron, 2006, Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction, Circulation, 114, 2232, 10.1161/CIRCULATIONAHA.106.644682 · DOI
  16. Sigwart, 1982, Improvement of left ventricular function after percutaneous transluminal coronary angioplasty, Am J Cardiol, 49, 651, 10.1016/0002-9149(82)91942-7 · DOI
  17. Brugada, 1989, Transcoronary chemical ablation of ventricular tachycardia, Circulation, 79, 475, 10.1161/01.CIR.79.3.475 · DOI
  18. Gleichmann, 1996, [Catheter treatment of hypertrophic obstructive cardiomyopathy], Dtsch Med Wochenschr, 121, 679, 10.1055/s-2008-1043055 · DOI
  19. Veselka, 2016, Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry, Eur Heart J, 37, 1517, 10.1093/eurheartj/ehv693 · DOI · Paper page
  20. Alam, 2006, Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies, J Interv Cardiol, 19, 319, 10.1111/j.1540-8183.2006.00153.x · DOI
  21. Sorajja, 2013, Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Catheter Cardiovasc Interv, 81, E58
  22. Singh, 2001, Anatomy of the first septal perforating artery: a study with implications for ablation therapy for hypertrophic cardiomyopathy, Mayo Clin Proc, 76, 799, 10.1016/S0025-6196(11)63224-2 · DOI
  23. Nagueh, 2011, Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry, J Am Coll Cardiol, 58, 2322, 10.1016/j.jacc.2011.06.073 · DOI
  24. Jensen, 2013, Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile, Heart, 99, 1012, 10.1136/heartjnl-2012-303339 · DOI
  25. Rigopoulos, 2016, Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy, Clin Res Cardiol, 105, 953, 10.1007/s00392-016-1005-x · DOI
  26. Liebregts, 2017, Outcomes of alcohol septal ablation in younger patients with obstructive hypertrophic cardiomyopathy, J Am Coll Cardiol Intv, 10, 1134, 10.1016/j.jcin.2017.03.030 · DOI
  27. Singh, 2016, A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy, Catheter Cardiovasc Interv, 88, 107

Cited by

Sorted by citations

See all 132

Metadata

Authors
Batzner, A., Pfeiffer, B., Neugebauer, A., Aicha, D., Blank, C., & Seggewiss, H.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2018-12
Volume
72
Issue
24
Pages
3087-3094
ISSN
0735-1097
DOI
10.1016/j.jacc.2018.09.064
Cited by
132
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review